AAAAAA
Results: 1-25/37
Authors:
NUTT D
Citation: D. Nutt, NATIONAL INSTITUTE OF DRUG-ABUSE RESEARCH MONOGRAPH SERIES - ASSESSING NEUROTOXICITY OF DRUGS OF ABUSE - ERINOFF,L, Addiction, 93(8), 1998, pp. 1270-1271
Authors:
NUTT D
JOHNSON FN
Citation: D. Nutt et Fn. Johnson, POTENTIAL APPLICATIONS OF VENLAFAXINE, Reviews in contemporary pharmacotherapy, 9(5), 1998, pp. 321-331
Authors:
NUTT D
Citation: D. Nutt, SUBSTANCE-P ANTAGONISTS - A NEW TREATMENT FOR DEPRESSION, Lancet, 352(9141), 1998, pp. 1644-1646
Authors:
CARPENE C
HUDSON D
MARTI L
REMAURY A
MORIN N
PREVOT D
LALIES M
NUTT D
LAFONTAN M
Citation: C. Carpene et al., EFFECTS OF IMIDAZOLINE I2-LIGANDS ON MONOAMINE-OXIDASE IN LIVER AND ADIPOCYTES - ACUTE TREATMENT INHIBITS ACTIVITY BUT CHRONIC TREATMENT DOES NOT REDUCE MONOAMINE-OXIDASE EXPRESSION, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 1942-1942
Authors:
CARPENE C
HUDSON D
MARTI L
REMAURY A
MORIN N
PREVOT D
LALIES M
NUTT D
LAFONTAN M
Citation: C. Carpene et al., EFFECTS OF IMIDAZOLINE I2-LIGANDS ON MONOAMINE-OXIDASE IN LIVER AND ADIPOCYTES - ACUTE TREATMENT INHIBITS ACTIVITY BUT CHRONIC TREATMENT DOES NOT REDUCE MONOAMINE-OXIDASE EXPRESSION, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 1947-1947
Authors:
HUDSON A
GOUGH R
NUTT D
Citation: A. Hudson et al., AUTORADIOGRAPHY OF IMIDAZOLINE-2 BINDING-SITES IN MARMOSET FOREBRAIN, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 35104-35104
Authors:
OBRIEN M
NUTT D
Citation: M. Obrien et D. Nutt, LOSS OF CONSCIOUSNESS AND POSTTRAUMATIC-STRESS-DISORDER - A CLUE TO ETIOLOGY AND TREATMENT, British Journal of Psychiatry, 173, 1998, pp. 102-104
Authors:
NUTT D
Citation: D. Nutt, PROMISES AND PITFALLS - COMMENTARY ON ANTELMAN ET-AL, TIME-DEPENDENT SENSITIZATION (TDS), POSSIBLE IMPLICATIONS FOR CLINICAL PSYCHOPHARMACOLOGY, Behavioural pharmacology, 8(6-7), 1997, pp. 515-516
Authors:
BURROWS G
EVANS L
BAUMHACKL U
HEBENSTREIT H
KATSCHNIG H
SCHONY W
SCHOLZ H
WILMOTTE J
CAMPOS J
COSTA D
NARDI A
VERSIANI M
DASILVA A
BOWEN R
BRADWEJN J
JOHNSTON D
PLAMONDON J
STEIN M
SWINSON R
CHNEIWEISS L
BELLAIRE W
OSTERHEIDER M
SONNTAG R
COOKSON J
FREEMAN C
HIRSCH S
MULLIN J
MURRAY R
NUTT D
PETURSSON H
ODONOGHUE F
MIN J
ALLGULANDER C
ANDERSCH S
BACKA H
REALINI R
SIEGEL JL
BULLER R
KATSCHNIG H
STEIN MB
BULLER R
Citation: G. Burrows et al., MOCLOBEMIDE IN SOCIAL PHOBIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-STUDY, European archives of psychiatry and clinical neuroscience, 247(2), 1997, pp. 71-80
Authors:
POTOKAR J
COUPLAND N
GLUE P
GROVES S
MALIZIA A
BAILEY J
WILSON S
NUTT D
Citation: J. Potokar et al., FLUMAZENIL IN ALCOHOL-WITHDRAWAL - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY, Alcohol and alcoholism, 32(5), 1997, pp. 605-611
Authors:
WEINSTEIN A
WILSON S
BAILEY J
MYLES J
NUTT D
Citation: A. Weinstein et al., IMAGERY OF CRAVING IN OPIATE ADDICTS UNDERGOING DETOXIFICATION, Drug and alcohol dependence, 48(1), 1997, pp. 25-31
Authors:
COUPLAND N
WILSON S
NUTT D
Citation: N. Coupland et al., ANTIDEPRESSANT DRUGS AND THE CARDIOVASCULAR-SYSTEM - A COMPARISON OF TRICYCLICS AND SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND THEIR RELEVANCE FOR THE TREATMENT OF PSYCHIATRIC-PATIENTS WITH CARDIOVASCULAR PROBLEMS, J PSYCHOPH, 11(1), 1997, pp. 83-92
Authors:
NUTT D
Citation: D. Nutt, MANAGEMENT OF PATIENTS WITH DEPRESSION ASSOCIATED WITH ANXIETY SYMPTOMS, The Journal of clinical psychiatry, 58, 1997, pp. 11-16
Authors:
NUTT D
Citation: D. Nutt, PSYCHOPHARMACOLOGY - AN INTRODUCTION, 3RD EDITION - SPIEGEL,R, British Journal of Psychiatry, 170, 1997, pp. 96-96
Authors:
NUTT D
Citation: D. Nutt, MIRTAZAPINE - PHARMACOLOGY IN RELATION TO ADVERSE-EFFECTS, Acta psychiatrica Scandinavica, 96, 1997, pp. 31-37
Authors:
ALTMAN J
EVERITT BJ
GLAUTIER S
MARKOU A
NUTT D
ORETTI R
PHILLIPS GD
ROBBINS TW
Citation: J. Altman et al., THE BIOLOGICAL, SOCIAL AND CLINICAL BASES OF DRUG-ADDICTION - COMMENTARY AND DEBATE, Psychopharmacology, 125(4), 1996, pp. 285-345
Authors:
POTOKAR J
NUTT D
Citation: J. Potokar et D. Nutt, PSYCHOPHARMACOLOGY, Current opinion in psychiatry, 9(1), 1996, pp. 98-104
Authors:
MONTGOMERY SA
BAKISH D
BULLER R
GJERRIS A
KATSCHNIG H
LECRUBIER Y
LEPINE JP
MAURI M
SATORIUS N
CAMERON A
CASSANO G
COSTAESILVA J
DENBOER JA
FREEMAN C
VONKNORRING L
LOO H
NUTT D
ROSENBERG R
Citation: Sa. Montgomery et al., ECNP POSITION PAPER ON SOCIAL PHOBIA - PROCEEDINGS FROM AN ECNP WORKSHOP IN JERUSALEM, OCTOBER 1994, European neuropsychopharmacology, 6(1), 1996, pp. 77-83
Authors:
WEINSTEIN A
WILSON S
BAILEY J
NUTT D
Citation: A. Weinstein et al., SEDATIVE ANTIDEPRESSANTS IMPAIR VISUAL DETECTION MECHANISMS IN HUMANS, J PSYCHOPH, 10(2), 1996, pp. 141-145
Authors:
NUTT D
Citation: D. Nutt, EARLY ACTION OF NEFAZODONE IN ANXIETY ASSOCIATED WITH DEPRESSION, J PSYCHOPH, 10, 1996, pp. 18-21
Authors:
SMITH A
NUTT D
Citation: A. Smith et D. Nutt, NORADRENALINE AND ATTENTION LAPSES, Nature, 380(6572), 1996, pp. 291-291
Authors:
COUPLAND N
MALIZIA A
BAILEY J
NUTT D
Citation: N. Coupland et al., THYROTROPIN-RELEASING-HORMONE - A POTENTIAL COMPARATOR FOR THE PANICOGENIC EFFECTS OF PENTAGASTRIN AND CCK, Biological psychiatry, 39(6), 1996, pp. 465-466
Authors:
GLUE P
WILSON S
COUPLAND N
BALL D
NUTT D
Citation: P. Glue et al., THE RELATIONSHIP BETWEEN BENZODIAZEPINE RECEPTOR SENSITIVITY AND NEUROTICISM, Journal of anxiety disorders, 9(1), 1995, pp. 33-45
Authors:
COUPLAND N
NUTT D
Citation: N. Coupland et D. Nutt, SUCCESSFUL TREATMENT OF TARDIVE OCULOGYRIC SPASMS WITH VITAMIN-E, Journal of clinical psychopharmacology, 15(4), 1995, pp. 285-286
Authors:
NUTT D
Citation: D. Nutt, THE ANXIETY FACTOR IN DEPRESSION, J PSYCHOPH, 9(2), 1995, pp. 185-189